3 completed, 1 not yet recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Not yet recruiting 1 |
Follow dapirolizumab pegol: new trials by email Literature Review of dapirolizumab pegol trials Research Report on dapirolizumab pegol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Lupus Erythematosus, Systemic (3) · Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Skin and Connective Tissue Diseases (2)
UCB Pharma (2) · Biogen (1) · UCB Biopharma SRL (1)
Belgium (2) · Bulgaria (2) · Germany (2) · Poland (1) · Romania (1) · Russia (1) · Spain (1) · United States (1)
2009 (1), 2025 (1)